Abstract #300506

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2003 Program page



JSM 2003 Abstract #300506
Activity Number: 118
Type: Topic Contributed
Date/Time: Monday, August 4, 2003 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #300506
Title: Causal Inference in Medical Device Trials: A Case Study
Author(s): Heng Li*+
Companies: FDA/CDRH
Address: HFZ-542, Rockville, MD, 20850,
Keywords: causal inference ; medical device ; clinical trial
Abstract:

Randomization has been a cornerstone of scientific experiments, especially those involving humans. In practice the eventual implementation of a randomized experiment may deviate from its original plan for various reasons. A well-known kind of such deviations is the so-called noncompliance of enrolled patients in clinical trials. Another, perhaps less well-known, example in clinical trials involves patient enrollment. In the medical devices arena, sometimes it may be difficult to enroll patients from the population identified in the original protocol into a trial containing a no-treatment arm after the availability of a device having similar indications as the investigational device. When this happens, another patient cohort may be created in which subjects are randomized to treatments with the investigational device and the device that has just become available on the market. A study planned as a randomized controlled trial comparing two treatments thus becomes two randomized trials on two possibly very different patient populations involving three treatments. We discuss how, in such an event, causal inference may be made on the safety and efficacy of the investigational device.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2003 program

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003